Medical Journals

Nucleotide Binding to Human Ump-cmp Kinase Using Fluorescent Derivatives -- a Screening Based on Affinity for the Ump-cmp Binding Site.

Authors:
  • Topalis Dimitri
  • Kumamoto Hiroki
  • Amaya Velasco Maria-Fernanda
  • Dugué Laurence
  • Haouz Ahmed
  • Alexandre Julie Anne C
  • Gallois-Montbrun Sarah
  • Alzari Pedro Maria
  • Pochet Sylvie
  • Agrofoglio Luigi André
  • Deville-Bonne Dominique

From: Laboratoire d’Enzymologie Moléculaire et Fonctionnelle, FRE 2852 CNRS-Paris 6, Institut Jacques Monod, Paris, France.

The FEBS journal

  • Publish Date: Jul 2007
  • ISSN: 1742-464X
  • Volume: 274
  • Issue: 14
  • Pages: 3704-14
  • Medium: Print
  • Language: English
  • Citation (JAMA): Topalis Dimitri, Kumamoto Hiroki, Amaya Velasco Maria-Fernanda, et al. Nucleotide Binding to Human Ump-cmp Kinase Using Fluorescent Derivatives -- a Screening Based on Affinity for the Ump-cmp Binding Site.. FEBS J. Jul 2007;274:3704-14

Abstract

Methylanthraniloyl derivatives of ATP and CDP were used in vitro as fluorescent probes for the donor-binding and acceptor-binding sites of human UMP-CMP kinase, a nucleoside salvage pathway kinase. Like all NMP kinases, UMP-CMP kinase binds the phosphodonor, usually ATP, and the NMP at different binding sites. The reaction results from an in-line phosphotransfer from the donor to the acceptor. The probe for the donor site was displaced by the bisubstrate analogs of the Ap5X series (where X = U, dT, A, G), indicating the broad specificity of the acceptor site. Both CMP and dCMP were competitors for the acceptor site probe. To find antimetabolites for antivirus and anticancer therapies, we have developed a method of screening acyclic phosphonate analogs that is based on the affinity of the acceptor-binding site of the human UMP-CMP kinase. Several uracil vinylphosphonate derivatives had affinities for human UMP-CMP kinase similar to those of dUMP and dCMP and better than that of cidofovir, an acyclic nucleoside phosphonate with a broad spectrum of antiviral activities. The uracil derivatives were inhibitors rather than substrates of human UMP-CMP kinase. Also, the 5-halogen-substituted analogs inhibited the human TMP kinase less efficiently. The broad specificity of the enzyme acceptor-binding site is in agreement with a large substrate-binding pocket, as shown by the 2.1 A crystal structure.

Mesh Headings (Keywords): Animals, Anthranilic Acids, Binding Sites, Biological Products, Cytidine Diphosphate, Cytidine Monophosphate, Fluorescent Dyes, Humans, Kinetics, Models, Molecular, Nucleoside-Phosphate Kinase, Protein Structure, Tertiary, Spectrometry, Fluorescence, Substrate Specificity, Uridine Monophosphate


Check for Full Text / PubMed Unique Identifier (PMID): 17608725


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.